MedPath

苏州盛达药业有限公司

Ownership
-
Established
1998-11-10
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

17

NMPA:17

Drug Approvals

Cefprozil

Product Name
头孢丙烯
Approval Number
国药准字H20123135
Approval Date
Aug 5, 2021
NMPA

Cefaclor

Product Name
头孢克洛
Approval Number
国药准字H20044490
Approval Date
Jul 14, 2020
NMPA

Cefradine

Product Name
头孢拉定
Approval Number
国药准字H20059824
Approval Date
Jul 14, 2020
NMPA

Ceftazidime

Product Name
头孢他啶
Approval Number
国药准字H20053432
Approval Date
Jul 14, 2020
NMPA

Cefpirome Sulfate

Product Name
硫酸头孢匹罗
Approval Number
国药准字H20052421
Approval Date
Jul 14, 2020
NMPA

Cefalotin Sodium

Product Name
头孢噻吩钠
Approval Number
国药准字H20034075
Approval Date
Jul 14, 2020
NMPA

Ceftriaxone Sodium

Product Name
头孢曲松钠
Approval Number
国药准字H20057356
Approval Date
Jul 14, 2020
NMPA

Cefminox Sodium

Product Name
头孢米诺钠
Approval Number
国药准字H20056635
Approval Date
Jul 14, 2020
NMPA

Cefamandole Nafate

Product Name
头孢孟多酯钠
Approval Number
国药准字H20063690
Approval Date
Jul 14, 2020
NMPA

Cefoperazone Sodium

Product Name
头孢哌酮钠
Approval Number
国药准字H20055459
Approval Date
Jul 14, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.